Detailed View
CORT - Corcept Therapeutics Incorporat
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
8,937,020,416
Adj EBIT (TTM)
-8,220,000
Enterprise Value
8,598,836,416
Last Price
83.25
Earnings Yield
-0.10%
Return on Capital
-1.23%
Capital
665,696,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 164,903,000 | -49,601,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 202,125,000 | 4,487,000 |
| 2025-09-30 | 10-Q | 2025 | 207,638,000 | 10,219,000 |
| 2025-06-30 | 10-Q | 2025 | 194,430,000 | 26,675,000 |
| 2025-03-31 | 10-Q | 2025 | 157,214,000 | 3,416,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 181,890,000 | 25,262,000 |
| 2024-09-30 | 10-Q | 2024 | 182,546,000 | 46,598,000 |
| 2024-06-30 | 10-Q | 2024 | 163,796,000 | 35,591,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.